Pharmacy Groups Ask FDA to Delay Enforcement of 'Track & Trace' Requirement

Pharmacy Groups Ask FDA to Delay Enforcement of 'Track & Trace' Requirement

ALEXANDRIA, Va. (June 24, 2015) – Three leading pharmacy organizations have asked the Food and Drug Administration (FDA) to help avoid any potential disruptions in the pharmaceutical supply chain by delaying enforcement of a July 1 product tracing deadline for dispensers. The American Pharmacists Association, National Alliance of State Pharmacy Associations and National Community Pharmacists Association made the request in a joint letter to FDA.

"With the December, 2014 FDA enforcement discretion delaying enforcement of the product tracing requirements until May 1, 2015, this implementation timetable has been compressed. Our organizations remain concerned that despite the extensive efforts by pharmacy and wholesale distributor associations to educate dispensers, some trading partners will encounter challenges beyond their control, with the possible outcome of disruptions in the supply chain," leaders of the three organizations wrote. "In order to forestall potential disruptions in the pharmaceutical supply chain, the undersigned organizations respectfully request that FDA utilize its enforcement discretion to delay the July 1 product tracing deadline for dispensers. Our members fully intend to continue intense, concerted efforts toward full compliance, but by exercising its enforcement authority, FDA would allow progress to continue while minimizing the risk of product shortages or disrupting patient access to prescription drugs."

Click here to view a copy of the full letter.

###The National Community Pharmacists Association (NCPA®) represents the interests of America's community pharmacists, including the owners of nearly 23,000 independent community pharmacies. Together they represent an $88.8 billion health care marketplace, dispense nearly 40% of all retail prescriptions, and employ more than 300,000 individuals, including over 62,000 pharmacists. To learn more, go to,, or follow NCPA on Twitter@Commpharmacy.

Kevin Schweers / John Norton

(703) 683-8200

[email protected] / [email protected]


Suggested Articles

Novavax has inked a $60 million contract with the U.S. Department of Defense to help fund U.S.-based manufacturing of its COVID-19 vaccine candidate.

Vaccine maker Inovio has accused a longtime manufacturing partner of hampering its efforts to produce 1 million doses of a potential COVID-19 vaccine.

Roche's global manufacturing leader Pierre-Alain Ruffieux will take the reins and oversee the Moderna COVID-19 vaccine collaboration.